Transient goiter enlargement after administration of 0.3 mg recombinant human thyrotropin in patients with benign nontoxic nodular goiter. A randomized, double-blind, cross-over trial

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageEnglish
JournalJournal of Clinical Endocrinology and Metabolism
Volume91
Pages (from-to)1317-1322
ISSN0021-972X
Publication statusPublished - 2006

Cite this